What was corrected and how
A subsequent correction by the company to the contents of an already published filing.
Notice concerning the repurchase and cancellation of the 10th and 11th Stock Acquisition Rights (with an exercise price adjustment clause) and the change in the use of funds raised, Notice concerning the issuance of new shares through a third-party allotment (contribution in kind) and the 12th Stock Acquisition Rights, the execution of a purchase agreement for the Stock Acquisition Rights, the issuance of the 1st Unsecured Bonds (privately placed bonds), the change in the use of funds raised from the 11th Stock Acquisition Rights (with an exercise price adjustment clause), partial amendments to the Articles of Incorporation, a capital and business alliance, and changes in the parent company and other affiliated companies
Disclosure material dated 11 December 2025, page 3: “II. Change in the use of funds raised” – “2. Details of changes” – “(1) Use of funds related to the 9th and 10th Stock Acquisition Rights” / excerpt from the “After change” section, Disclosure material dated 24 February 2026, page 31: “(4) Equity financing over the past three years” – “Issuance of the 9th and 10th Stock Acquisition Rights through a third-party allotment” / excerpt from the relevant section
December 2025–February 2028, ②December 2025–February 2028
December 2025–August 2027, ②December 2025–August 2027
This correction corrects an error in the stated planned expenditure period in materials already released. There is no change to the use or amount of the funds raised.
In preparing the disclosure material dated 11 December 2025, when the use of funds was changed from “development of new businesses (M&A and investment in new companies)” to “repayment of borrowings,” the stated planned expenditure period remained unchanged from the previous version. The same wording was also carried over into the disclosure material dated 24 February 2026.
| Item | Details |
|---|---|
| Disclosure subject to correction | Notice concerning the repurchase and cancellation of the 10th and 11th Stock Acquisition Rights (with an exercise price adjustment clause) and the change in the use of funds raised, Notice concerning the issuance of new shares through a third-party allotment (contribution in kind) and the 12th Stock Acquisition Rights, the execution of a purchase agreement for the Stock Acquisition Rights, the issuance of the 1st Unsecured Bonds (privately placed bonds), the change in the use of funds raised from the 11th Stock Acquisition Rights (with an exercise price adjustment clause), partial amendments to the Articles of Incorporation, a capital and business alliance, and changes in the parent company and other affiliated companies |
| Original disclosure date | 11 December 2025, 24 February 2026 |
| Location of correction | Disclosure material dated 11 December 2025, page 3: “II. Change in the use of funds raised” – “2. Details of changes” – “(1) Use of funds related to the 9th and 10th Stock Acquisition Rights” / excerpt from the “After change” section, Disclosure material dated 24 February 2026, page 31: “(4) Equity financing over the past three years” – “Issuance of the 9th and 10th Stock Acquisition Rights through a third-party allotment” / excerpt from the relevant section |
| Details of correction | December 2025–February 2028, ②December 2025–February 2028 → December 2025–August 2027, ②December 2025–August 2027 |
| Reason for correction | In preparing the disclosure material dated 11 December 2025, when the use of funds was changed from “development of new businesses (M&A and investment in new companies)” to “repayment of borrowings,” the stated planned expenditure period remained unchanged from the previous version. The same wording was also carried over into the disclosure material dated 24 February 2026. |
| Impact on Business Performance | This correction corrects an error in the stated planned expenditure period in materials already released. There is no change to the use or amount of the funds raised. |
The reasons the company gives
The company's own explanation, not something inferred from the numbers.When the use of funds was changed in the disclosure material dated 11 December 2025, the stated planned expenditure period remained unchanged from the previous version, and that wording was carried over into the disclosure material dated 24 February 2026.